HWAM
PRCT icon

Hennion & Walsh Asset Management’s Procept Biorobotics PRCT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,343
Closed -$259K – 999
2026
Q1 		$259K Sell
10,343
-210
-2% -$5.92K 0.01% 856
2025
Q4 		$332K Buy
10,553
+7
+0.1% +$232 0.01% 805
2025
Q3 		$376K Sell
10,546
-89
-0.8% -$4.06K 0.01% 783
2025
Q2 		$613K Buy
10,635
+278
+3% +$15.7K 0.02% 616
2025
Q1 		$603K Buy
10,357
+733
+8% +$50K 0.03% 586
2024
Q4 		$775K Buy
9,624
+3,702
+63% +$316K 0.04% 524
2024
Q3 		$474K Buy
5,922
+1,273
+27% +$90.4K 0.02% 634
2024
Q2 		$284K Buy
+4,649
New +$276K 0.01% 741

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hennion & Walsh Asset Management's PRCT Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Procept Biorobotics (PRCT) in Q2 2026, closing a stake of 10,343 shares — an estimated $259K sold.

Hennion & Walsh Asset Management first reported a position in PRCT in Q2 2024 and held it in 8 quarters. The position peaked at $775K in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Hennion & Walsh Asset Management reported no remaining Procept Biorobotics position as of Q2 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 10,343 Procept Biorobotics shares in Q2 2026, an estimated $259K.
  • Hennion & Walsh Asset Management first reported a position in Procept Biorobotics in Q2 2024 and held it in 8 quarters.
  • Hennion & Walsh Asset Management's Procept Biorobotics position peaked at $775K in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.